European Alliance for Personalised Medicine (EAPM) shared a post on LinkedIn:
“EAPM at ISLB Meeting – Pompei, Italy
We are happy to share that towards the end of next month, EAPM will be present at the ‘Path to Leading Innovation in Liquid Biopsy’ meeting, organised by the International Society of Liquid Biopsy, taking place in Pompei on 22–23 May 2026.
We are honored to be part of this important scientific exchange bringing together leading experts, researchers, and stakeholders to discuss the latest developments and future directions in liquid biopsy.
Denis Horgan, Executive Director of EAPM, will participate as a speaker, contributing to discussions on advancing innovation and implementation in personalised cancer care.
Our participation will also represent the SPARC.eu project, reinforcing our commitment to supporting the integration of liquid biopsy into clinical practice.
On the second day, SPARC will be featured in a roundtable focused on projects exploring different approaches to the clinical implementation of liquid biopsy across diverse settings. The discussion will address how to bridge existing gaps in real-world adoption, taking into account differences across countries, healthcare systems, and clinical environments.
This will be an important opportunity to present SPARC’s vision and contribute to the broader dialogue on translating scientific innovation into effective and equitable healthcare solutions.
Events like this are key to strengthening collaboration and ensuring that innovation in personalised cancer medicine reaches patients across Europe and beyond.”
Other articles about EAPM on OncoDaily.